Skip to main content

RedHill Biopharma Ltd.

RDHL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001553846

In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.

13F holders, Q2 2022

Institutional positions in RedHill Biopharma Ltd. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
−1 vs. Q1 2022
Shares held
4.17M
−553.2K (−11.7%) vs. Q1 2022
Total value
$3.89M
−$8.01M (−67.3%) vs. Q1 2022
New holders
4
13 more added
Sold out
5
14 more reduced

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RDHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 48 institutions
Q1 2021: 64 institutionsQ2 2021: 55 institutionsQ3 2021: 61 institutionsQ4 2021: 57 institutionsQ1 2022: 49 institutionsQ2 2022: 48 institutionsQ3 2022: 43 institutionsQ4 2022: 41 institutionsQ1 2023: 20 institutionsQ2 2023: 21 institutionsQ3 2023: 19 institutionsQ4 2023: 19 institutionsQ1 2024: 17 institutionsQ2 2024: 18 institutionsQ3 2024: 11 institutionsQ4 2024: 11 institutionsQ1 2025: 12 institutionsQ2 2025: 12 institutionsQ3 2025: 14 institutionsQ4 2025: 17 institutionsQ1 2026: 16 institutionsQ2 2026: 14 institutions
Value heldQ2 2022: $3.89M
Q1 2021: $77.4MQ2 2021: $49.1MQ3 2021: $24.5MQ4 2021: $12.5MQ1 2022: $11.9MQ2 2022: $3.89MQ3 2022: $1.46MQ4 2022: $1.51MQ1 2023: $1.20MQ2 2023: $419.2KQ3 2023: $781.9KQ4 2023: $449.2KQ1 2024: $1.40MQ2 2024: $719.7KQ3 2024: $48.8KQ4 2024: $103.5KQ1 2025: $80.5KQ2 2025: $37.9KQ3 2025: $51.2KQ4 2025: $514.5KQ1 2026: $386.5KQ2 2026: $270.0K
Institutions holding RDHL and their total value by quarter
QuarterHoldersValue
Q2 202614$270.0K
Q1 202616$386.5K
Q4 202517$514.5K
Q3 202514$51.2K
Q2 202512$37.9K
Q1 202512$80.5K
Q4 202411$103.5K
Q3 202411$48.8K
Q2 202418$719.7K
Q1 202417$1.40M
Q4 202319$449.2K
Q3 202319$781.9K
Q2 202321$419.2K
Q1 202320$1.20M
Q4 202241$1.51M
Q3 202243$1.46M
Q2 202248$3.89M
Q1 202249$11.9M
Q4 202157$12.5M
Q3 202161$24.5M
Q2 202155$49.1M
Q1 202164$77.4M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding RedHill Biopharma Ltd.; share changes are against Q1 2022.

Institutions holding RDHL in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
ARK Investment Management LLCSuperinvestorARK Invest1,045,023$1.17M0.01%+183,225+21.3%Added
Disciplined Growth Investors Inc810,646$705.0K0.02%−1,139,356−58.4%Reduced
Gagnon Securities LLC375,346$327.0K0.07%+8,000+2.2%Added
Millennium Management LLC372,930$324.0K0.00%+372,930New
BlackRock Inc.356,675$311.0K0.00%−818−0.2%Reduced
Morgan Stanley144,222$125.0K0.00%+105,106+268.7%Added
Claret Asset Management Corp95,430$83.0K0.02%00.0%Unchanged
Federation des caisses Desjardins du Quebec93,876$81.7K0.00%+34,395+57.8%Added
Ancora Advisors, LLC82,048$71.0K0.00%00.0%Unchanged
Creative Planning67,601$59.0K0.00%00.0%Unchanged
CIBC World Markets Inc.65,575$57.0K0.00%00.0%Unchanged
State Street Corp52,198$45.0K0.00%+167+0.3%Added
Barclays PLC51,000$44.0K0.00%−25,500−33.3%Reduced
Susquehanna International Group, LLP49,720$43.0K0.00%+10,254+26.0%Added
Group One Trading, L.P.48,895$43.0K0.00%+31,888+187.5%Added
Annandale Capital, LLC43,532$38.0K0.02%00.0%Unchanged
National Bank of Canada43,000$37.0K0.00%00.0%Unchanged
Virtu Financial LLC42,940$37.0K0.00%+16,076+59.8%Added
Geode Capital Management, LLC41,637$36.0K0.00%00.0%Unchanged
Eaton Vance Management40,417$35.0K0.00%00.0%Unchanged
Goldman Sachs Group Inc36,321$32.0K0.00%−637−1.7%Reduced
Acadian Asset Management LLC31,306$27.0K0.00%+14,526+86.6%Added
Mercer Global Advisors Inc26,559$23.0K0.00%00.0%Unchanged
UBS Group AG18,957$17.0K0.00%+1,473+8.4%Added
Gsa Capital Partners LLP16,548$14.0K0.00%+16,548New
Two Sigma Securities, LLC14,810$13.0K0.00%−10,689−41.9%Reduced
D.A. Davidson & Co.14,500$13.0K0.00%−2,300−13.7%Reduced
Verition Fund Management LLC13,636$12.0K0.00%+13,636New
Commonwealth Equity Services, LLC11,937$10.0K0.00%−300−2.5%Reduced
Simplex Trading, LLC11,592$10.0K0.00%+2,359+25.5%Added
Jane Street Group, LLC10,770$9.00K0.00%−17,505−61.9%Reduced
Bank of New York Mellon Corp10,000$9.00K0.00%−10,000−50.0%Reduced
Steward Partners Investment Advisory, LLC7,500$7.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)4,164$4.00K0.00%−2,478−37.3%Reduced
Citigroup Inc4,871$4.00K0.00%+3,736+329.2%Added
Advisor Group Holdings, Inc.4,600$4.00K0.00%00.0%Unchanged
JPMorgan Chase & Co2,095$2.00K0.00%−3,888−65.0%Reduced
Atticus Wealth Management, LLC2,425$2.00K0.00%00.0%Unchanged
Wells Fargo & Company1,943$2.00K0.00%+1,000+106.0%Added
BNP Paribas Arbitrage, SA1,235$1.07K0.00%+1,235New
Bank of America Corp1,300$1.00K0.00%−831−39.0%Reduced
Royal Bank of Canada1,329$1.00K0.00%−271−16.9%Reduced
BDO Wealth Advisors, LLC1,000$1.00K0.00%00.0%Unchanged
US Bancorp702$1.00K0.00%00.0%Unchanged
Costello Asset Management, INC300$00.00%00.0%Unchanged
Signaturefd, LLC100$00.00%00.0%Unchanged
Daiwa Securities Group Inc.70$00.00%00.0%Unchanged
IFP Advisors, Inc300––−300−50.0%Reduced
Candriam Luxembourg S.C.A.0$00.00%−71,267−100.0%Sold out
Citadel Advisors LLC0$00.00%−57,713−100.0%Sold out
Cambridge Investment Research Advisors, Inc.0$00.00%−25,632−100.0%Sold out
Cutler Group LP0$00.00%−200−100.0%Sold out
Bedel Financial Consulting, Inc.0$00.00%−66−100.0%Sold out